If you're looking into a low usage setup, this is perfect.
If you're looking into a low usage setup, this is perfect.
#$PSTV’s focus on coverage, coding, and Medicare access for CNSide could help convert a niche CNS cancer test into a scalable diagnostic business over time.
#PSTV #Cancer #HealthCare #Medtech
prismmarketview.com/plus-therape...
#$PSTV’s focus on coverage, coding, and Medicare access for CNSide could help convert a niche CNS cancer test into a scalable diagnostic business over time.
#PSTV #Cancer #HealthCare #Medtech
prismmarketview.com/plus-therape...
#MedicalInnovation #HealthTech
#sentimentscore = 0.9908
#MedicalInnovation #HealthTech
#sentimentscore = 0.9908
www.biopharmcatalyst.com/news/2025/pl...
www.biopharmcatalyst.com/news/2025/pl...
Targeting recurrent glioblastoma with Rhenium-186 nanoliposome delivered via CED. Phase 2 readout in 2026 could be a major re-rating event.
Full deep dive + valuation scenarios: frisbyresearch.substack.com/p/plus-thera...
#Biotech #Microcap #GBM
Targeting recurrent glioblastoma with Rhenium-186 nanoliposome delivered via CED. Phase 2 readout in 2026 could be a major re-rating event.
Full deep dive + valuation scenarios: frisbyresearch.substack.com/p/plus-thera...
#Biotech #Microcap #GBM